STOCK TITAN

Morgan Stanley (NYSE: MS) updates prospectus for Series M preferred stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
424B3

Rhea-AI Filing Summary

Morgan Stanley filed a prospectus addendum to offer Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series M using the prospectus dated April 8, 2026. The addendum replaces the prior prospectus dated November 16, 2020 and notes that Morgan Stanley & Co. LLC may sell shares in market-making transactions.

Positive

  • None.

Negative

  • None.
Registration Number 333-293641 Prospectus addendum cover
Prospectus date (current) April 8, 2026 Accompanying prospectus dated April 8, 2026
Prospectus date (superseded) November 16, 2020 Prospectus being superseded
Fixed-to-Floating Rate financial
"SHARES FIXED-TO-FLOATING RATE NON-CUMULATIVE PREFERRED STOCK"
A fixed-to-floating rate is a type of loan or investment that starts with a fixed interest rate for a certain period, meaning the payments stay the same, then switches to a variable rate that can change over time based on market conditions. This matters because it offers the stability of fixed payments initially, but also the flexibility to benefit if interest rates drop later.
Non-Cumulative Preferred financial
"NON-CUMULATIVE PREFERRED STOCK, SERIES M"
Prospectus Addendum regulatory
"Prospectus Addendum to the Prospectus dated April 8, 2026"
Market‑making transactions market
"will, and other affiliates of Morgan Stanley may, use this prospectus addendum in connection with offers and sales of the shares in market-making transactions"

 

Filed Pursuant to Rule 424(b)(3)
Registration Statement No. 333-293641

 

Prospectus Addendum to 

the Prospectus dated April 8, 2026

 

 

SHARES OF 

FIXED-TO-FLOATING RATE NON-CUMULATIVE PREFERRED STOCK,

SERIES M

 

You should read the accompanying prospectus supplement, which gives the specific terms of the offered shares, together with the accompanying prospectus dated April 8, 2026 of Morgan Stanley. When you read the prospectus supplement with the specific terms of the offered shares, please note that all references in the prospectus supplement to the prospectus dated November 16, 2020, or to any sections of that document, should refer instead to the accompanying prospectus dated April 8, 2026, or to the corresponding section of the accompanying prospectus.

 

The accompanying prospectus dated April 8, 2026 supersedes the prospectus dated November 16, 2020.

 

Morgan Stanley & Co. LLC will, and other affiliates of Morgan Stanley may, use this prospectus addendum in connection with offers and sales of the shares in market-making transactions.

 

The shares are not deposits or savings accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality, nor are they obligations of, or guaranteed by, a bank.

 

 

MORGAN STANLEY

 

April 8, 2026 

 

 

FAQ

What does Morgan Stanley's prospectus addendum for Series M (MS) state?

The addendum updates the offering terms for Series M preferred stock and references the prospectus dated April 8, 2026. It supersedes the prior prospectus dated November 16, 2020 and permits market‑making sales by Morgan Stanley & Co. LLC.

Will Morgan Stanley receive proceeds from these Series M sales (MS)?

The addendum states Morgan Stanley & Co. LLC will and other affiliates may use the addendum for market‑making transactions. It does not state proceeds treatment or pricing in the excerpt; specific proceeds terms are in the accompanying prospectus supplement.

What are the key features named for the offered security in the MS addendum?

The security is described as Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series M. The excerpt highlights that the shares are not bank deposits and are not FDIC‑insured; specific rate and terms are in the prospectus supplement.

Does the addendum change the effective prospectus date for the offering (MS)?

Yes. The addendum instructs readers to refer to the prospectus dated April 8, 2026, which supersedes the prospectus dated November 16, 2020. The prospectus supplement provides the specific offering terms.